Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Biosig Technologies
(NQ:
BSGM
)
0.4700
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biosig Technologies
< Previous
1
2
Next >
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
July 31, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024
July 25, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
June 10, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
May 21, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
May 03, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
April 30, 2024
Mr. Amato will also serve on the Company’s Board of Directors
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Engages Consulting Firm for Business Model Strategies
April 04, 2024
BAIPC will work to deploy a series of solutions to transform BioSig’s future course
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Reduction of its Workforce
February 20, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
February 06, 2024
Company sees clinical adoption and usage of its novel Near Field Tracking algorithm, proven to reduce ablation time by approximately 66%.
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Reverse Stock Split
January 31, 2024
Common Stock Will Begin Trading on Split-Adjusted Basis on February 2, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
January 30, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
December 06, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 13, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 09, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
November 02, 2023
PURE EP™ subscriber community now includes two of top three U.S. health systems in cardiology: Mayo Clinic-Phoenix and Cleveland Clinic
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
November 07, 2023
32-year career in medical device and electrophysiology business expansion for industry bellwethers; led multiple company exits including a $1B sale in 2018 Part of leadership team that grew Johnson &...
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI
November 01, 2023
IP portfolio includes U.S. and worldwide utility and design patents and pending applications in the U.S., Europe, and Asia-Pacific
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
August 24, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
August 23, 2023
Cleveland Clinic, the #1 heart center in the Nation, signs on as first subscriber to receive latest software advancements in intracardiac signal visualization
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
August 22, 2023
Latest Software Release Supports Electrophysiologists with Visualizing Heart Patterns Difficult to Recognize with the Naked Eye
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
July 25, 2023
Deal to create additional value through subsidiary to advance Artificial Intelligence strategy without dilution to BioSig Technologies Shareholders
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
July 20, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Joins Webull Corporate Connect
June 29, 2023
Webull’s investor community can now access real-time BioSig investor communications and Q&A
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
June 27, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
May 25, 2023
Via
ACCESSWIRE
New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias
May 19, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
May 03, 2023
Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP™ Platform
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces New Advisory Board Member Edwin Wang
March 27, 2023
From
BioSig Technologies, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.